8-KLeadership Changes

Cencora, Inc. 8-K Report, Executive Changes (Aug 14, 2026)

Filed August 14, 2026For Securities:COR

Summary

Cencora, Inc. (COR) announced on August 14, 2026, that Dr. Lorence H. Kim has resigned from the Board of Directors, effective immediately. This departure is attributed to Dr. Kim's appointment as Chief Financial Officer at Commonwealth Fusion Systems, Inc., requiring his full attention and time commitment to his new role. The company has clarified that Dr. Kim's resignation is not a result of any disagreements concerning Cencora's operations, policies, or practices, and the Board has expressed gratitude for his service. This change in board composition is the primary disclosure in this 8-K filing. While the resignation is noted, the company has provided assurances that it is not indicative of internal discord. Investors should note this change as a routine board adjustment often seen when executives take on significant new responsibilities elsewhere. The filing does not contain any information related to financial performance, new business initiatives, or material agreements.

Key Highlights

  • 1Dr. Lorence H. Kim has resigned from Cencora, Inc.'s Board of Directors, effective August 13, 2026.
  • 2The resignation is due to Dr. Kim's new role as Chief Financial Officer at Commonwealth Fusion Systems, Inc.
  • 3Dr. Kim needs to dedicate additional time to his responsibilities at Commonwealth Fusion Systems.
  • 4The company states that Dr. Kim's resignation is not due to any disagreements regarding Cencora's operations, policies, or practices.
  • 5Cencora, Inc. expressed thanks to Dr. Kim for his service.
  • 6The filing is classified as an 8-K, indicating a material event.
  • 7The report was signed by Elizabeth S. Campbell, Executive Vice President and Chief Legal Officer.

Frequently Asked Questions

Dr. Kim resigned to accept the position of Chief Financial Officer at Commonwealth Fusion Systems, Inc. and to dedicate more time to his new professional responsibilities there.

No, Cencora has stated that Dr. Kim's resignation is not due to any disagreements with the company regarding its operations, policies, or practices.

The filing explicitly states that the resignation is not due to any disagreements concerning Cencora's operations, policies, or practices. It appears to be a standard board change related to an individual taking on new, time-intensive executive responsibilities at another company.

This 8-K filing primarily informs investors about a change in board composition. The key takeaway is the departure of a director due to external executive commitments, with assurances of no internal disputes. It does not provide updates on financial performance or strategic direction.